REGN
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a biotechnology company focused on antibody therapies, with its strongest political signal being $33.8M in annual doctor payments and a direct holding by a former President valued between $15,001-$50,000.
Govt Dependence
15/100
Regulatory Density
85/100
Lobbying Intensity
20/100
Political Signal
NEUTRAL
BusinessWhat REGN does
Regeneron Pharmaceuticals develops and commercializes antibody-based treatments for serious medical conditions, including eye diseases, cancer, and inflammatory disorders. Its revenue is primarily driven by product sales for EYLEA and Dupixent, with significant investment in research and development. The company engages in substantial physician outreach, evidenced by over $33.8M in annual payments to doctors and healthcare entities.
12 months past · 3 months futureREGN activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
249 trading days ·
13 congressional trades shown
·
0 insider buys
·
11 13F filings
·
3 past bill actions
·
2 upcoming markups
Executive Branch ConflictsREGN held by Trump-administration officials
1 cabinet/senior official reported REGN positions in OGE Form 278 disclosures across 5 filings.
Donald J. Trump
President · White House
REGENERON PHARMACEUTICALS INC
Donald J. Trump
President · White House
REGENERON PHARMACEUTICALS INC
Donald J. Trump
President · White House
REGENERON PHARMACEUTICALS INC
Donald J. Trump
President · White House
Regeneron Pharmaceuticals
pharma
Donald J. Trump
President · White House
REGENERON PHARMACEUTICALS INC
Lifetime Government AwardsREGN federal contracts
REGN doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Smart Money · 13F HoldingsHedge funds holding REGN
$679.86B
Total REGN held by tracked 13F funds
6
Funds with REGN positions
Two Sigma Investments
$627.57B
+189%
5 overlap
2026-03-31
Renaissance Technologies
$51.61B
+636%
5 overlap
2026-03-31
Millennium Management
$293M
+89%
5 overlap
2025-12-31
Citadel Advisors
$211M
+31%
5 overlap
2025-12-31
D.E. Shaw & Co.
$116M
-80%
5 overlap
2025-12-31
Bridgewater Associates
$56M
-69%
5 overlap
2025-12-31
Politicians Trading REGNMembers of Congress with recent REGN positions
10 politicians traded REGN across 65 disclosed transactions totaling $618K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just REGN). 0-30 LOW · 30-60 MID · 60+ HIGH.
Ro Khanna
13 buys
19 sells
$256K
2026-04-13
LOW · 0
Jonathan L. Jackson
4 sells
$81K
2024-11-13
LOW · 1
Jefferson Shreve
2 sells
$65K
2025-04-07
LOW · 0
Josh Gottheimer
8 sells
$64K
2025-01-24
LOW · 1
Julie Johnson
2 buys
4 sells
$48K
2025-04-01
LOW · 15
Robert P. Bresnahan
2 buys
4 sells
$48K
2025-05-15
LOW · 0
Byron Donalds
2 sells
$16K
2025-04-10
LOW · 1
Greg Landsman
2 sells
$16K
2024-10-15
LOW · 0
Gilbert Ray Cisneros
1 buy
1 sell
$16K
2026-05-15
HIGH · 61
Julia Letlow
1 buy
$8K
2026-02-12
LOW · 1
Congressional TradesWho in Congress is trading REGN
2026-05-15
Gilbert Ray Cisneros
Sale
$1,001 - $15,000
2026-04-13
Ro Khanna
Purchase
$1,001 - $15,000
2026-02-12
Julia Letlow
Purchase
$1,001 - $15,000
2026-01-29
Ro Khanna
Sale
$1,001 - $15,000
2026-01-23
Ro Khanna
Purchase
$1,001 - $15,000
2025-11-18
Gilbert Ray Cisneros
Purchase
$1,001 - $15,000
2025-11-03
Ro Khanna
Purchase
$1,001 - $15,000
2025-09-29
Ro Khanna
Sale
$1,001 - $15,000
2025-09-29
Ro Khanna
sale
$1,001 - $15,000
2025-08-04
Ro Khanna
Purchase
$1,001 - $15,000
2025-08-26
Ro Khanna
purchase
$1,001 - $15,000
2025-08-26
Ro Khanna
Purchase
$1,001 - $15,000
30+ trades on file · most recent 2026-06-08
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting REGNLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.2001 · 119th
Action for Dental Health Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
Political ProfileWhere REGN sits in Washington
[object Object]
STRUCTURAL: Strong committee alignment via Sen. Collins (Appropriations Chair, HELP member) and $150K in lobbying focused on government funding. EVIDENTIARY: Zero corporate insider buys in 180 days (tier F score), but active congressional trading (16 trades in 12 months) and a direct executive branch holding. Net: High regulatory density and structural access are offset by a lack of bullish insider evidence.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened scrutiny of physician payment programs under the Sunshine ActCenters for Medicare & Medicaid Services (CMS)"`get_political_influence.doctor_payments` shows $33.8M in total payments for 2024."
-
Potential drug pricing legislation impacting revenueCongress, Department of Health and Human Services (HHS)"Recent bill_impacts list shows 8 healthcare bills with estimated revenue impacts ranging from $4.1M to $6.1M."
Regulatory opportunities
-
Funding for coronavirus therapeutics and biodefense initiativesDepartment of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA)"`Lobbying filings` show specific issues: 'Coronavirus therapeutic funding; biodefense funding'."
Capitol Hill AlliesChampions & critics
Congressional champions
Congressional critics
- No specific congressional critics identified.
LobbyingWho's hired to advocate for REGN
CRANE STRATEGIES · $150K government
Member intelligence layer
Live signals + predictions for REGN — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades REGN
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout REGN & political exposure
Does Regeneron Pharmaceuticals, Inc. (REGN) hold federal contracts?
No direct prime contracts reported in USASpending.gov for Regeneron Pharmaceuticals, Inc.. Companies in the semiconductor and AI hardware sectors often sell to the federal government via prime contractors and cloud resellers (Microsoft Azure, AWS, Lockheed Martin systems integration) rather than as direct primes.
Which Trump cabinet officials own REGN stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in REGN on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded REGN stock?
351 congressional trades by 22 unique members of Congress, most recently on 2026-05-15. See the Congressional Trading panel for politician-by-politician breakdown.
What is REGN political risk profile?
Government dependence: 15/100. Lobbying intensity: 20/100. Political signal: neutral. Donor party split: R 60% / D 40%.
How does GovGreed track REGN political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. REGN data is updated daily from these official federal sources.